Market Access News | pharmaphorum

News

EU due to meet with pharma today to discuss tariffs

European Commission President Ursula von der Leyen is scheduled to meet with EU pharma leaders today about how to respond to US tariffs.

News

Trump blocks plan for Medicare to cover weight-loss drugs

A proposal by the Biden administration to cover weight-loss medicines for obesity under Medicare has been axed by the White House.

News

AZ grabs pair of EU approvals for top cancer drugs

AstraZeneca is celebrating two approvals for cancer drugs Imfinzi and Enhertu in the EU as it faces increased competition to its top-seller Tagrisso.

News

Uplizna is first drug FDA-cleared for rare disease IgG4-RD

Amgen has bagged a second indication for its B cell-depleting therapy Uplizna after the FDA cleared it for rare inflammatory disease IgG4-RD.

News

Germany will reimburse haemophilia gene therapy Hemgenix

Germany has agreed to reimburse CSL Behring's haemophilia B gene therapy Hemgenix with a 'unique' outcomes-based payment model.

News

Novartis gets FDA nod for second of three IgAN drugs

Novartis has claimed accelerated approval in the US for Vanrafia, one of a trio of drugs it hopes will revolutionise the treatment of IgA nephropathy.

EU due to meet with pharma today to discuss tariffs

Trump blocks plan for Medicare to cover weight-loss drugs

AZ grabs pair of EU approvals for top cancer drugs

Uplizna is first drug FDA-cleared for rare disease IgG4-RD

Germany will reimburse haemophilia gene therapy Hemgenix

Novartis gets FDA nod for second of three IgAN drugs

FDA starts review of AZ's COPD blockbuster hope

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks